Rani Therapeutics Holdings CEO Talat Imran receives $12M in 2021
Rani Therapeutics Holdings reports 2021 executive compensation
By ExecPay News
Published: April 13, 2022
Rani Therapeutics Holdings reported fiscal year 2021 executive compensation information on April 13, 2022.
In 2021, four executives at Rani Therapeutics Holdings received on average a compensation package of $5.4M, a 835% increase compared to previous year.
Average pay of disclosed executives at Rani Therapeutics Holdings
Talat Imran, Chief Executive Officer, received $12M in total. 93% of Imran's compensation, or $11M, was in option awards. Imran also received $375K in non-equity incentive plan and $408K in salary.
Mir Hashim, Chief Scientific Officer, received a compensation package of $5M, which increased by 694% compared to previous year. 46% of the compensation package, or $2.3M, was in stock awards.
Svai Sanford, Chief Financial Officer, earned $4.7M in 2021, a 799% increase compared to previous year.
Mir Imran, Chief Executive Officer, received $33K in 2021.
Related executives
You may also like
Source: SEC filing on April 13, 2022.